Implementation Testing of the Heart Failure Carer Support Programme in the United Kingdom
Led by Queen's University, Belfast · Updated on 2026-06-02
360
Participants Needed
5
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
Sponsors
Q
Queen's University, Belfast
Lead Sponsor
B
Belfast Health and Social Care Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
Heart failure is a common condition in the United Kingdom, where many patients depend on family members or friends to help care for them. These caregivers often face challenges and stress due to their role, which can affect their own mental and physical health. The Heart Failure Carer Support Programme (HELP) is the first intervention developed in the UK to support these carers by helping them care for themselves and the patients they assist. The study aims to find the best way to provide HELP across the UK and measure its effects on both carers and patients.
HELP is delivered by heart failure nurses to about 180 informal carers across three UK locations. The programme consists of six weekly online support group sessions lasting one hour each, led by specialist nurses via video calls. Carers also receive an educational booklet and access to a website for additional guidance. Patients supported by these carers, also around 180 individuals, will provide information to assess how HELP affects both carers and patients over time.
Participants will provide information at different times: before the programme starts, during the six weeks of HELP, immediately after finishing, and six months later. Researchers will collect data through interviews, logs, and questionnaires to understand how well HELP is delivered and what factors influence its success. They will also measure hospital admissions, doctor visits, and quality of life for patients, as well as burden, preparedness, and quality of life for carers. The study will last up to one year, including monitoring costs and long-term effects.
CONDITIONS
Brief Title
Heart Failure Carer Support Programme: Implementation Testing in the UK.
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Carers aged 18 years or older
Able to use digital devices, participate in conversations, and read written materials
Providing regular unpaid care for a person with diagnosed heart failure who has symptoms or had a medical episode in the past 6 months
Able to speak and understand English
Patients aged 18 years or older
Diagnosed with heart failure and receiving standard therapies
Experiencing symptoms or had one episode of decompensation in the past 6 months
Receiving regular unpaid support from a carer
Able to engage in conversation and read written materials
Able to speak and understand English
You will not qualify if you...
Lacking capacity to give consent
Under 18 years old
Patients whose carer refused to participate in the programme
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual) for eligibility assessment
Outpatient Treatment
Duration - 6 weeks
Participants engage in a 6-week psychoeducational support programme consisting of weekly online group support sessions and self-directed learning through educational materials.
Weekly online support group sessions via ZOOM
Follow-up
Duration - Up to 6 months after treatment
Participants are followed for up to 6 months to assess experiences, behavioural impacts, and long-term adherence to the support programme.
Assessments at baseline, 6 weeks, and 6 months with additional weekly perspectives collected during the 6-week programme
Evaluating the implementation and impact of the HEart faiLure carer support Programme (HELP) in the United Kingdom: A study protocol for a multi-centre, mixed-method, implementation study.